Oligopeptide B and its antibacterial application
An oligopeptide and anti-bacterial technology, applied in the field of biomedicine, can solve the problems of drug resistance of pathogenic bacteria threatening human health and clinical treatment of diseases, and achieve the effect of convenient synthesis and broad antibacterial spectrum
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0014] Design and synthesis of oligopeptide B of the present invention
[0015] 1. According to the current major international antimicrobial peptide databases (http: / / www.imtech.res.in / raghava / antibp / ; http: / / aps.unmc.edu / AP / main.php; http: / / www.bbcm .univ.trieste.it / ; http: / / penbase.immunaqua.com / ) the sequence of antimicrobial peptides, analyze the corresponding relationship between its primary structure and activity, and design artificial oligopeptide sequences.
[0016] 2. Use the protein analysis database http: / / www.expasy.org / to analyze the similarity of the secondary structure between the peptide sequence of known activity and the designed oligopeptide sequence, and to modify the design sequence in combination with the prediction of other physical and chemical parameters.
[0017] 3. Send the designed artificial oligopeptide sequence to a biological company for synthesis or use an automatic peptide synthesizer to synthesize the sequence. HPLC detection purity is greater tha...
Embodiment 2
[0021] Using liquid growth inhibition method to detect the antibacterial activity of the oligopeptide B of the present invention
[0022] 2.1 Materials and reagents
[0023] 1) The oligopeptide B of the present invention is synthesized by Shanghai Shenggong Biological Engineering Technology Service Co., Ltd., ampicillin (Amp) is a product of Solarbio Company, a disposable filter is a product of PALL Company of the United States, and other pharmaceutical reagents are domestically pure.
[0024] 2) Select Gram-positive bacteria: Bacillus subtilis (Ehrenberg) Cohn, Staphyloccocus aureus Rosenbach, Micrococcus luteus, Sarcina ureae, Bacillus thuringiensis (Bacillus thuringiensis), Bacillus megaterium (Bacillus megaterium); Gram-negative bacteria: Escherichia coli, Vibrio, Klebsiella pneumoniae, Serratia marcescens (Serratia marcescens), Proteus, Bacillus licheniformis; Fungi: Fusarium solani, Fusarium oxysporum, Colietetrichum lagenarium, Apple anthracnose The germ (Gloeosporium album)...
Embodiment 3
[0038] Escherichia coli was used as indicator bacteria.
[0039] The oligopeptide B of the present invention with a mass concentration of 40 mg / mL was applied to Escherichia coli for 10 min, 20 min, 30 min, 45 min, 60 min, 90 min, 120 min, and 180 min, respectively.
[0040] The inhibition curve of Escherichia coli shows that the inhibitory effect of the oligopeptide B of the present invention on the bacteria starts to play within 20 minutes, the inhibition rate can reach more than 75% after 45 minutes, and more than 90% after 90 minutes.
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com